The Acute Coronary Syndrome Study. Organization and Treatment of Patients With Acute Coronary Syndrome, With a Focus on Costs, Organization and Security
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 400
- 试验地点
- 2
- 主要终点
- Cost effectiveness. Adverse medical events
研究概览
简要总结
The investigators will make a prospective study in which they will look at the economics and security of the treatment of patients with acute coronary syndrome.
The investigators want to do a randomized trial. One group will be treated as they have been treated at Ullevål University Hospital (UUS) in recent years, and the other group will be returned to their refering hospital the same day. The objective of this study will be to provide increased knowledge about whether the rapid discharge from the intervention center is associated with differences in costs or security.
详细描述
The topic of this study is whether patients with Acute coronary syndrome (ACS)may can be transferred to their refering hospital same day that they arrived intervention hospital.
This is to see if one can reduce the hospital stay and costs for the intervention center, and the total hospitalization time.
and this rapid transport not give more medical complications
Our 1 hypothesis is that patients with ACS, who are transported back to the refering hospital the same day, will reduce the length of stay in intervention center without an increase for the stay at the refering hospital.
Our 2 hypothesis is that patients with ACS, who are transported back to the refering hospital the same day as the treatment is performed, have no more complications than those who stay overnight in the intervention hospital.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients with acute coronary syndrome who are referred from other hospitals
排除标准
- •Patients younger than 18years.
- •Known mental retardation, dementia or harmful use of alcohol or drugs.
- •Allergy or intolerance to ASA and / or clopidogrel.
- •Patients who have previously been involved in this study.
- •Acute STEMI infarction for less than 72 hours ago.
结局指标
主要结局
Cost effectiveness. Adverse medical events
时间窗: 30 days and a year's events
次要结局
- SF-36(One year)